Hong, Liang
Hu, Zhihang
Sun, Siqi
Tang, Xiangru
Wang, Jiuming
Tan, Qingxiong
Zheng, Liangzhen
Wang, Sheng
Xu, Sheng
King, Irwin
Gerstein, Mark
Funding for this research was provided by:
Innovation and Technology Fund (GHP/065/21SZ)
Research Grants Council, University Grants Committee (CUHK 24204023, PF22-73180)
Article History
Received: 15 September 2023
Accepted: 12 July 2024
First Online: 9 August 2024
Competing interests
: S.W. and L.Z. are the cofounders of Zelixir Biotech Co., Ltd. The other authors declare no competing interests.